Benjamin Ian Bearnot, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Opioid-Related Disorders | 15 | 2023 | 2152 | 2.190 |
Why?
|
Endocarditis | 4 | 2022 | 350 | 1.310 |
Why?
|
Methamphetamine | 1 | 2021 | 165 | 0.670 |
Why?
|
Substance Abuse, Intravenous | 2 | 2022 | 530 | 0.660 |
Why?
|
Needles | 2 | 2020 | 451 | 0.640 |
Why?
|
Geographic Information Systems | 2 | 2018 | 281 | 0.640 |
Why?
|
Refuse Disposal | 1 | 2018 | 31 | 0.630 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2018 | 166 | 0.590 |
Why?
|
Buprenorphine | 5 | 2023 | 655 | 0.580 |
Why?
|
Social Stigma | 2 | 2020 | 768 | 0.520 |
Why?
|
Substance-Related Disorders | 4 | 2021 | 4416 | 0.520 |
Why?
|
Medical Staff, Hospital | 1 | 2019 | 601 | 0.480 |
Why?
|
Central Nervous System Stimulants | 1 | 2021 | 1176 | 0.420 |
Why?
|
Internal Medicine | 1 | 2019 | 1051 | 0.380 |
Why?
|
Health Services Accessibility | 2 | 2019 | 5421 | 0.380 |
Why?
|
Epidemics | 1 | 2017 | 512 | 0.370 |
Why?
|
Alcoholism | 2 | 2019 | 1972 | 0.370 |
Why?
|
Analgesics, Opioid | 6 | 2023 | 3792 | 0.340 |
Why?
|
Endocarditis, Bacterial | 2 | 2022 | 444 | 0.290 |
Why?
|
Self Report | 1 | 2018 | 3721 | 0.280 |
Why?
|
Psychiatry | 1 | 2019 | 1690 | 0.270 |
Why?
|
Hospitals | 1 | 2019 | 3873 | 0.250 |
Why?
|
Mobile Health Units | 2 | 2015 | 92 | 0.220 |
Why?
|
Subacute Care | 2 | 2022 | 178 | 0.190 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5332 | 0.190 |
Why?
|
Smoking Cessation | 3 | 2022 | 2053 | 0.180 |
Why?
|
San Francisco | 1 | 2020 | 162 | 0.180 |
Why?
|
Drug Users | 1 | 2022 | 134 | 0.180 |
Why?
|
Boston | 4 | 2021 | 9326 | 0.170 |
Why?
|
Narcotic Antagonists | 2 | 2023 | 585 | 0.170 |
Why?
|
Continuity of Patient Care | 2 | 2019 | 1069 | 0.160 |
Why?
|
Harm Reduction | 1 | 2020 | 144 | 0.160 |
Why?
|
Biomedical Research | 1 | 2014 | 3421 | 0.160 |
Why?
|
Residence Characteristics | 2 | 2019 | 2087 | 0.160 |
Why?
|
Marijuana Smoking | 1 | 2022 | 258 | 0.160 |
Why?
|
Hallucinogens | 1 | 2022 | 197 | 0.160 |
Why?
|
Alcoholic Beverages | 1 | 2019 | 264 | 0.140 |
Why?
|
Emergency Service, Hospital | 1 | 2017 | 7860 | 0.140 |
Why?
|
Cannabis | 1 | 2022 | 437 | 0.130 |
Why?
|
Attitude | 1 | 2020 | 776 | 0.130 |
Why?
|
Cross-Sectional Studies | 7 | 2022 | 26063 | 0.130 |
Why?
|
Canada | 1 | 2021 | 2119 | 0.130 |
Why?
|
Humans | 30 | 2023 | 760437 | 0.120 |
Why?
|
Health Facilities | 1 | 2019 | 580 | 0.110 |
Why?
|
Commerce | 1 | 2019 | 604 | 0.110 |
Why?
|
Medically Underserved Area | 1 | 2015 | 256 | 0.110 |
Why?
|
Reminder Systems | 1 | 2016 | 387 | 0.110 |
Why?
|
Hospitals, General | 1 | 2017 | 798 | 0.100 |
Why?
|
Appointments and Schedules | 1 | 2016 | 443 | 0.100 |
Why?
|
Sex Distribution | 1 | 2017 | 2281 | 0.100 |
Why?
|
Adult | 15 | 2022 | 220781 | 0.100 |
Why?
|
Interviews as Topic | 1 | 2019 | 2683 | 0.100 |
Why?
|
Age Distribution | 1 | 2017 | 2878 | 0.090 |
Why?
|
Massachusetts | 2 | 2021 | 8826 | 0.090 |
Why?
|
United States | 6 | 2023 | 72202 | 0.090 |
Why?
|
Truth Disclosure | 1 | 2015 | 433 | 0.090 |
Why?
|
South Africa | 5 | 2015 | 1840 | 0.090 |
Why?
|
Social Class | 1 | 2019 | 2003 | 0.090 |
Why?
|
HIV Infections | 5 | 2015 | 17328 | 0.080 |
Why?
|
Bacteriological Techniques | 1 | 2010 | 279 | 0.080 |
Why?
|
Ambulatory Care Facilities | 1 | 2015 | 933 | 0.080 |
Why?
|
HIV Seropositivity | 1 | 2015 | 960 | 0.080 |
Why?
|
Community Health Services | 1 | 2013 | 656 | 0.080 |
Why?
|
Rural Population | 2 | 2019 | 2279 | 0.080 |
Why?
|
GTP-Binding Protein Regulators | 1 | 2007 | 12 | 0.080 |
Why?
|
Male | 13 | 2021 | 360035 | 0.080 |
Why?
|
Anti-Retroviral Agents | 2 | 2015 | 1781 | 0.080 |
Why?
|
GTP-Binding Protein beta Subunits | 1 | 2007 | 33 | 0.070 |
Why?
|
Retinal Bipolar Cells | 1 | 2007 | 46 | 0.070 |
Why?
|
Opiate Substitution Treatment | 2 | 2023 | 443 | 0.070 |
Why?
|
Mass Screening | 2 | 2015 | 5424 | 0.070 |
Why?
|
Young Adult | 5 | 2020 | 59068 | 0.070 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2007 | 195 | 0.070 |
Why?
|
Patient Compliance | 1 | 2016 | 2689 | 0.070 |
Why?
|
Fellowships and Scholarships | 1 | 2014 | 1117 | 0.060 |
Why?
|
Health Personnel | 1 | 2019 | 3331 | 0.060 |
Why?
|
Female | 12 | 2020 | 391875 | 0.060 |
Why?
|
Middle Aged | 7 | 2020 | 220382 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3344 | 0.050 |
Why?
|
Hospitalization | 2 | 2022 | 10698 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 9046 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2019 | 22097 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8623 | 0.040 |
Why?
|
Cohort Studies | 2 | 2021 | 41366 | 0.040 |
Why?
|
Prevalence | 4 | 2022 | 15698 | 0.040 |
Why?
|
Primary Health Care | 1 | 2016 | 4674 | 0.040 |
Why?
|
Mycobacterium tuberculosis | 1 | 2010 | 1912 | 0.040 |
Why?
|
Aged | 4 | 2020 | 168840 | 0.040 |
Why?
|
Referral and Consultation | 2 | 2022 | 3596 | 0.040 |
Why?
|
Ontario | 1 | 2019 | 399 | 0.040 |
Why?
|
Tuberculosis | 1 | 2010 | 2012 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2022 | 80430 | 0.040 |
Why?
|
Anti-HIV Agents | 2 | 2010 | 4518 | 0.030 |
Why?
|
Retina | 1 | 2007 | 2652 | 0.030 |
Why?
|
Adolescent | 3 | 2019 | 88196 | 0.030 |
Why?
|
Analgesics | 1 | 2022 | 1070 | 0.030 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2016 | 394 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1087 | 0.030 |
Why?
|
Suicide, Attempted | 1 | 2022 | 1397 | 0.030 |
Why?
|
Odds Ratio | 2 | 2019 | 9639 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2018 | 64591 | 0.020 |
Why?
|
Suicidal Ideation | 1 | 2022 | 1443 | 0.020 |
Why?
|
Urban Population | 1 | 2019 | 2032 | 0.020 |
Why?
|
Family Characteristics | 1 | 2015 | 1000 | 0.020 |
Why?
|
Patient Care Team | 1 | 2021 | 2517 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2023 | 5491 | 0.020 |
Why?
|
Vulnerable Populations | 1 | 2015 | 700 | 0.020 |
Why?
|
Sputum | 1 | 2010 | 506 | 0.020 |
Why?
|
Protein Kinase C-alpha | 1 | 2007 | 113 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2569 | 0.020 |
Why?
|
Program Evaluation | 1 | 2015 | 2493 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2010 | 1083 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2757 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 2010 | 1481 | 0.020 |
Why?
|
Microscopy | 1 | 2010 | 886 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2007 | 877 | 0.020 |
Why?
|
Prospective Studies | 3 | 2015 | 54339 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2318 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9267 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14565 | 0.010 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2010 | 1896 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6086 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7817 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21322 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14661 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39078 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 74055 | 0.010 |
Why?
|
Mice | 1 | 2007 | 81402 | 0.000 |
Why?
|
Animals | 1 | 2007 | 168253 | 0.000 |
Why?
|